24 August 2022
Camellia Plc (CAM.L) issues the following update on trading for the year and confirms the interim results release date….
23 August 2022
Unaudited half-year results for the six months ended 30th June 2022…
19 August 2022
“HICL” or the “Company” and, together with its subsidiaries, the “Group”, the London-listed infrastructure investment company managed by InfraRed Capital Partners Limited (“InfraRed” or the “Investment Manager”)….
17 August 2022
Preliminary Results for the year ended 30 April 2022…
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for momelotinib, a potential new medicine with a proposed differentiated mechanism of action that may address the significant unmet medical needs of myelofibrosis patients with anaemia. …
Statement: Zantac (ranitidine) U.S. litigation Notice of Voluntary Dismissal to be filed in Bayer case, first scheduled Zantac trial GSK did not settle Plaintiff…
16 August 2022
AstraZeneca's supplemental New Drug Application (sNDA) for Lynparza (olaparib) in combination with abiraterone and prednisone or prednisolone has been accepted and granted Priority Review in the US for the treatment of adult patients with metastatic castration-resistant prostate cancer (mCRPC)….
16 August 2022 LONDONMETRIC PROPERTY PLC LONDONMETRIC SELLS FOUR ASSETS FOR £26 MILLION LondonMetric Property Plc (“LondonMetric”) has sold four assets, in two separate…